Адъювантное лечение рака толстой кишки

1. Барсуков Ю.А., Кныш В.И. Современные возможности лечения колоректального рака. Соврем. онкол. 2006; 8 (2): 7–16.
2. Andre Т, Colin Р, Louvet С et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks adjuvant therapy in stage II and III colon cancer: results of а randomized trial. J Clin Oncol 2003; 21 (15): 2896–903.
3. Andre Т, Boni С, Mounedji-Boudiaf et al. Oxaliplatin, fluorouracil and leucovorinas adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–51.
4. Arnold D, Schmoll H-J. (Neo-) adjuvant treatment in colorectal cancer. Ann Oncol 2005; 15 (Suppl. 2): 133–40.
5. Cassidy J, Twelves С, Nowacki М et al. Improved safety of capecitabine versus bolus 5-fluorouracil/leucovorin adjuvant therapy for colon cancer (the Х-АСТ phase III study). Gastrointestinal Cancer Symposium 2004; Abstr. 219.
6. Cervantes А, Chirivella I, Rodrigllez-Braun Е et al. А multimodality approach to localized rectal cancer. Ann Oncol 2006; 17 (Suppl. 10): 129–34.
7. De Gramont А, Boni С, Navarro М et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results оп the MOSAIC tria1, including survival, with а median follow-up of six years. ASCO 2007; 25 (suppl. 1): abstr. 4007.
8. Feig В, Chang G. Sentinel node assessment in colorectal сапl potential advantages and obstacles. ASCO 2007 Ed. Book. 196–8.
9. GiIl S, Loprizini CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III соlon cancer: Who benefits and bу haw much? J Clin Oncol 2004; 22(10): 1–10.
10. Gray RG, Barnwel1 J, Hills R et аl. QUASAR: А randomized study of adjuvant chemotherapy vs observation including 3238 colorectal canсеr patients. Рrос ASCO 2004; аbstr. 3501.
11. Glynne-Jones R, Sebag-Montefiore D, Маngаhn TS et al. А phase I dose escalation study of continuous oral capecitabine with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann Oncol 2006; 17: 50–6.
12. Наllеr DG, Catalano PJ, Macdonald JS, Мауег RJ. Fluorouracil (FU), leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089. Proc ASCO, 1998; аbstr. 982.
13. Hamaguchi T, Shirao К, Moriya Y et al. Adjuvant chemotherapy with uracil-tegafur (UFT) for stage III colorectal cancer: Final results of randomized trials bу the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC). Proc ASCO 2007; 25: abstr. 4049.
14. International Multicentre Pooled Ana1ysis of Colon Cancer Trials (IМPАСТ) investigators efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345(8955): 939–44.
15. International Multicentre Pooled analysis of В2 Colon Cancer Trials (IMPACT 82) Investigators Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999; 17: 1356–63.
16. Johnston Р. Clinical or molecular factors for treatment decision. Ann Oncol 2006; 17 (Suppl. 9): 37.
17. Kalоfоnоs НР, Pentheroudakis G, Rigatos S et al. А rаndоmаsеd phasе III trial of adjuvant radio-chemotherapy соmрaring irinоtесаn (СРТ-11), 5FU and leucovorin to 5FU and leucovorin in patients with rectal cancer. Ann Oncol 2006; 17 (Suppl. 9): Abstr. 3320 (Р. 116).
18. Корес JA, Yothers G, Ganz РА et al. Сравнение качества жизни операбельных больных раком ободочной кишки на фоне перорального и внутривенного введения химиопрепаратов: результаты исследования С-06, проведенного в рамках National Surgical Аdjuvаnt Breast and Bowel Project. J Clin Оnсоl (рус. изд.) 2007; 25(4): 424–30.
19. Moertel CG, Flеming TR, Масdоnаld JC et al. Fluorouracil plus levamisole as effective adjuvant therapy of resected colon саrсinоmа. N Engl J Med 1990; 332(6): 235–8.
20. Moertel CG, Fleming TR, Macdonald JC et al. Fluorouracil plus levamisole as effective аdjuvаnt therapy after resection of stage III соlоп саrсinоmа: А finаl report. Ann Intеrn Med 1995; 122: 321–6.
21. О'Соnеll MJ, Laurie JA, Каhn М et аl. Prospectively rаndоmizеd trial of postoperative adjuvant chemotherapy in patients with high-risk соlon cancer. J Clin Oncol 1998; 16(1): 295–300.
22. O'Dwyer PJ, Eckhardt SG, Haller DG et аl. Recommendation of Gаstrоintеstinаl Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J Clin Оnсоl 2007; 25: 2313–21.
23. QUASAR Collaborative group, Comparison of fluorouracil with аdditiоnаl levamisole, higher-dose folinic acid, or botl1, as аn adjuvant chemotherapy for colorectal саnсеr: а randomized trial. Lancet 2000; 355: 1588–96.
24. Saini А, Norman AR, Cunningham D et аl. Twelve weeks of protracted venus infusion of fluorouracil is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. Br J Cancer 2003; 88: 1859–65.
25. Sargent DJ, Goldberg RM, Jacobson SD et al. А pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345(15): 1091–7.
26. Sargent DJ, Wieand S, Benedetti J et al. Disease-free survival vs overall survival as а primary endpoint for аdjuvаnt colon cancer studies: individual patients data fron 12, 915 patients оп 15 randomised trials. Proc ASCO 2004; abstr. 3502.
27. Sauer R, Becker Н, Hohenberger W et al. Preoperative chemo/radiotherapy as compared with post-operative chemo/radiotherapy for locally advanced rectal cancer. N Engl J Med 2004; 351: 1731–40.
28. Tepper JE, O'Conell MJ, Petroni GR et al. Adjuvant postoperative fluоrоurасil-mоdulаtеd chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114. J Clin Oncol 1997; 15: 2030–9.
29. Twelves С, Scheithauer W, McKendrick J et al. 5-year overall survival update from Х-АСТ trial of capecitabine vs 5-FU/LV as adjuvant therapy for stage III colon cancer. Еur J Cancer 2007; 5 (5? suppl.): 384 (Ро6587).
30. Van Cutsem Е, Labianka R, Hossteld D et al. Randomized phase III trial comparing infused irinotecan/5-fluоrоnrасil/folinic acid versus 5FU/FA in stage III colon cancer patients (РЕТАСС-3). Proc ASCO 2005; 24: abstr.
31. Wiggers Т. Multidisciplinary treatment of loсаllу advanced rectal cancer. Eur J Cancer 2007; 5 (5, suppl.): 375–6.
32. Wolmark N, Wickerham DI, Fisher В et аl. Postoperative adjuvant therapy for Dukes В and С adenocarcinoma: In "NIН Consensus Development Conference Adjuvant Therapy for patients with colon and rectum cancer". 1990; 45–6.
33. Wolmark N, Rockette Н, Mamounas Е et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil and leucovorin and levamisole in patients with Dukes' В and С carcinoma of the colon: results from National Surgical Adjuvant Breast and bowel Project С-О4. J Clin Oncol 1999; 17(11): 3553–9.

Е.В.Артамонова*, К.Э.Подрегульский**

*РОНЦ РАМН;
**кафедра онкологии РМАПО, Москва